{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:06:17Z","timestamp":1789506377221,"version":"build-2803163510"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T00:00:00Z","timestamp":1592438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R268-406 206-3927"],"award-info":[{"award-number":["R268-406 206-3927"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002739","name":"Aarhus University Research Foundation","doi-asserted-by":"publisher","award":["AUFF-E-215-FLS-8-66"],"award-info":[{"award-number":["AUFF-E-215-FLS-8-66"]}],"id":[{"id":"10.13039\/501100002739","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Independent Research Fud Denmark-Medical Sciences","award":["#4004-00047B"],"award-info":[{"award-number":["#4004-00047B"]}]},{"DOI":"10.13039\/501100002739","name":"Aarhus University Research Foundation","doi-asserted-by":"publisher","award":["AUFF-E-215-FLS-8\u201366"],"award-info":[{"award-number":["AUFF-E-215-FLS-8\u201366"]}],"id":[{"id":"10.13039\/501100002739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>We investigated a patient with systemic juvenile idiopathic arthritis (sJIA) and recurrent macrophage activation syndrome (MAS) to discover genetic and immunological contributing factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Severe recurrent MAS motivated whole exome sequencing (WES) to identify genetic variants potentially involved in disease pathogenesis. In vitro peripheral blood mononuclear cell (PBMC) stimulations for cytokine expression and caspase-1 activity assays as well as NF-\u03baB reporter luciferase assays were performed to functionally characterize variants.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>WES revealed an extremely rare heterozygous missense variant, c.482G&amp;gt;A, p.R161H in the CASP1 gene encoding pro-caspase-1. Lipopolysaccharide (LPS) stimulation of patient PBMCs induced high levels of IL-6 compared to controls, and activation of the NLRP3 inflammasome resulted in increased production of IL-1\u03b2 and IL-18 as well as significantly elevated caspase-1 activity. Constitutive and inducible levels of IL-18 and IFN\u03b3 in whole blood were markedly elevated. Expression of the CASP1 variant in an NF-\u03baB reporter luciferase assay induced increased NF-\u03baB activation in a RIP2-dependent manner. The disease course of the patient was complicated by severe recurrent MAS. However, dual IL-1 and IL-6 blockade caused disease remission.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>For the first time, we demonstrate the involvement of a CASP1 variant in sJIA and recurrent MAS. This variant is gain-of-function for both inflammasome and NF-\u03baB activation leading to increased production of IL-6, IL-1\u03b2 and IL-18. Although dual IL-1 and IL-6 blockade may be beneficial in patients, in whom single treatment is not sufficient to control MAS, caution should be practiced, since interstitial lung disease may progress despite apparent clinical and biochemical remission.<\/jats:p><\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa242","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T19:20:49Z","timestamp":1586978449000},"page":"3099-3105","source":"Crossref","is-referenced-by-count":20,"title":["Systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome due to a CASP1 variant causing inflammasome hyperactivation"],"prefix":"10.1093","volume":"59","author":[{"given":"Sofie E","family":"J\u00f8rgensen","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Aarhus University Hospital"},{"name":"Department of Biomedicine, Aarhus University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Christiansen","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Aarhus University Hospital"},{"name":"Department of Clinical Immunology, Aarhus University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"H\u00f8st","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Aarhus University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Glerup","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Aarhus University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitte","family":"Mahler","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Aarhus University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira M","family":"Lausten","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Aarhus University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Henrik","family":"Gad","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Genetics, Aarhus University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rune","family":"Hartmann","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Genetics, Aarhus University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troels","family":"Herlin","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Aarhus University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1853-9704","authenticated-orcid":false,"given":"Trine H","family":"Mogensen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Aarhus University Hospital"},{"name":"Department of Biomedicine, Aarhus University"},{"name":"Department of Clinical Medicine, Aarhus University, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,6,18]]},"reference":[{"key":"2020092423551881700_keaa242-B1","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nrrheum.2011.68","article-title":"Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions","volume":"7","author":"Mellins","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"2020092423551881700_keaa242-B2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.berh.2018.02.002","article-title":"Systemic juvenile idiopathic arthritis: new insights into pathogenesis and cytokine directed therapies","volume":"31","author":"Pardeo","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2020092423551881700_keaa242-B3","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.pcl.2018.04.005","article-title":"Systemic juvenile idiopathic arthritis","volume":"65","author":"Lee","year":"2018","journal-title":"Pediatr Clin North Am"},{"key":"2020092423551881700_keaa242-B4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fimmu.2019.00119","article-title":"The immunology of macrophage activation syndrome","volume":"10","author":"Crayne","year":"2019","journal-title":"Front Immunol"},{"key":"2020092423551881700_keaa242-B5","first-page":"1133","article-title":"Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis","volume":"34","author":"Behrens","year":"2007","journal-title":"J Rheumatol"},{"key":"2020092423551881700_keaa242-B6","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","article-title":"Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis","volume":"367","author":"De Benedetti","year":"2012","journal-title":"N Engl J Med"},{"key":"2020092423551881700_keaa242-B7","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1056\/NEJMoa1205099","article-title":"Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis","volume":"367","author":"Ruperto","year":"2012","journal-title":"N Engl J Med"},{"key":"2020092423551881700_keaa242-B8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/rheumatology\/kez282","article-title":"IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome","volume":"59","author":"Yasin","year":"2020","journal-title":"Rheumatology"},{"key":"2020092423551881700_keaa242-B9","doi-asserted-by":"crossref","first-page":"15970","DOI":"10.1073\/pnas.1520779112","article-title":"HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis","volume":"112","author":"Ombrello","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020092423551881700_keaa242-B10","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI2629","article-title":"The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis","volume":"102","author":"Fishman","year":"1998","journal-title":"J Clin Invest"},{"key":"2020092423551881700_keaa242-B11","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1002\/art.11300","article-title":"The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families","volume":"48","author":"Ogilvie","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2020092423551881700_keaa242-B12","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/art.38877","article-title":"Association of a mutation in LACC1 with a monogenic form of systemic juvenile idiopathic arthritis","volume":"67","author":"Wakil","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2020092423551881700_keaa242-B13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12969-016-0124-2","article-title":"Juvenile arthritis caused by a novel FAMIN (LACC1) mutation in two children with systemic and extended oligoarticular course","volume":"14","author":"Kallinich","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"key":"2020092423551881700_keaa242-B14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/humu.22169","article-title":"Naturally occurring genetic variants of human caspase-1 differ considerably in structure and the ability to activate interleukin-1beta","volume":"34","author":"Luksch","year":"2013","journal-title":"Hum Mutat"},{"key":"2020092423551881700_keaa242-B15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"2020092423551881700_keaa242-B16","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1084\/jem.20142274","article-title":"Functional IRF3 deficiency in a patient with herpes simplex encephalitis","volume":"212","author":"Andersen","year":"2015","journal-title":"J Exp Med"},{"key":"2020092423551881700_keaa242-B17","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"2020092423551881700_keaa242-B18","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.4049\/jimmunol.1203524","article-title":"Human procaspase-1 variants with decreased enzymatic activity are associated with febrile episodes and may contribute to inflammation via RIP2 and NF-kappaB signaling","volume":"192","author":"Heymann","year":"2014","journal-title":"J Immunol"},{"key":"2020092423551881700_keaa242-B19","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/art.23199","article-title":"Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis","volume":"58","author":"Hazen","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2020092423551881700_keaa242-B20","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/rheumatology\/kep418","article-title":"Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis","volume":"49","author":"Vastert","year":"2010","journal-title":"Rheumatology"},{"key":"2020092423551881700_keaa242-B21","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/ng.3089","article-title":"An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome","volume":"46","author":"Canna","year":"2014","journal-title":"Nat Genet"},{"key":"2020092423551881700_keaa242-B22","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1164\/rccm.201903-0659OC","article-title":"Synergistic signaling of TLR and IFN\u03b1\/\u03b2 facilitates escape of IL-18 expression from endotoxin tolerance","volume":"201","author":"Verweyen","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2020092423551881700_keaa242-B23","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.jaci.2016.10.022","article-title":"Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition","volume":"139","author":"Canna","year":"2017","journal-title":"J Allergy Clin Immunol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/10\/3099\/33790339\/keaa242.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/10\/3099\/33790339\/keaa242.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T01:13:34Z","timestamp":1615252414000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/59\/10\/3099\/5859204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,18]]},"references-count":23,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,6,18]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa242","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,6,18]]}}}